Telesis Bio, Inc.
TBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $215 | $636 | $5,700 | $9,733 |
| - Cash | $2 | $30 | $83 | $13 |
| + Debt | $34 | $21 | $17 | $8 |
| Enterprise Value | $248 | $627 | $5,634 | $9,728 |
| Revenue | $28 | $27 | $11 | $7 |
| % Growth | 0.3% | 148.4% | 67.9% | – |
| Gross Profit | $17 | $16 | $4 | $4 |
| % Margin | 61.6% | 56.8% | 38.9% | 55.1% |
| EBITDA | -$40 | -$44 | -$36 | -$16 |
| % Margin | -147.2% | -159% | -326% | -241.1% |
| Net Income | -$48 | -$48 | -$39 | -$18 |
| % Margin | -173.5% | -176.7% | -352.8% | -273.9% |
| EPS Diluted | -1.59 | -1.65 | -1.33 | -0.62 |
| % Growth | 3.6% | -24.1% | -114.5% | – |
| Operating Cash Flow | -$35 | -$39 | -$37 | -$15 |
| Capital Expenditures | -$2 | -$4 | -$2 | -$0 |
| Free Cash Flow | -$37 | -$43 | -$39 | -$16 |